Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling
- PMID: 22308236
- DOI: 10.1093/cvr/cvs082
Proarrhythmia in KCNJ2-linked short QT syndrome: insights from modelling
Abstract
Aims: One form of the short QT syndrome (SQT3) has been linked to the D172N gain-in-function mutation to Kir2.1, which preferentially increases outward current through channels responsible for inward rectifier K(+) current (I(K1)). This study investigated mechanisms by which the Kir2.1 D172N mutation facilitates and perpetuates ventricular arrhythmias.
Methods and results: The ten Tusscher et al. model for human ventricular action potentials (APs) was modified to incorporate changes to I(K1) based on experimentally observed changes to Kir2.1 function: both heterozygous (WT-D172N) and homozygous (D172N) mutant scenarios were studied. Cell models were incorporated into heterogeneous one-dimensional (1D), 2D tissue, and 3D models to compute the restitution curves of AP duration (APD-R), effective refractory period (ERP-R), and conduction velocity (CV). Temporal and spatial vulnerability of ventricular tissue to re-entry was measured and dynamic behaviour of re-entrant excitation waves (lifespan and dominant frequency) in 2D and 3D models of the human ventricle was characterized. D172N 'mutant' I(K1) led to abbreviated APD and ERP, as well as steeper APD-R and ERP-R curves. It reduced tissue excitability at low excitation rates but increased it at high rates. It increased tissue temporal vulnerability for initiating re-entry, but reduced the minimal substrate size necessary to sustain re-entry. SQT3 'mutant' I(K1) also stabilized and accelerated re-entrant excitation waves, leading to sustained rapid re-entry.
Conclusion: Increased I(K1) due to the Kir2.1 D172N mutation increases arrhythmia risk due to increased tissue vulnerability, shortened ERP, and altered excitability, which in combination facilitate initiation and maintenance of re-entrant circuits.
Similar articles
-
Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):186-97. doi: 10.1016/j.pbiomolbio.2008.10.010. Epub 2008 Nov 9. Prog Biophys Mol Biol. 2008. PMID: 19041665
-
Effects of amiodarone on short QT syndrome variant 3 in human ventricles: a simulation study.Biomed Eng Online. 2017 Jun 7;16(1):69. doi: 10.1186/s12938-017-0369-0. Biomed Eng Online. 2017. PMID: 28592292 Free PMC article.
-
Modelling the effects of quinidine, disopyramide, and E-4031 on short QT syndrome variant 3 in the human ventricles.Physiol Meas. 2017 Sep 21;38(10):1859-1873. doi: 10.1088/1361-6579/aa8695. Physiol Meas. 2017. PMID: 28812984
-
Cardiac potassium inward rectifier Kir2: Review of structure, regulation, pharmacology, and arrhythmogenesis.Heart Rhythm. 2021 Aug;18(8):1423-1434. doi: 10.1016/j.hrthm.2021.04.008. Epub 2021 Apr 20. Heart Rhythm. 2021. PMID: 33857643 Free PMC article. Review.
-
Arrhythmogenic Mechanisms in Hypokalaemia: Insights From Pre-clinical Models.Front Cardiovasc Med. 2021 Feb 3;8:620539. doi: 10.3389/fcvm.2021.620539. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 33614751 Free PMC article. Review.
Cited by
-
Evaluating pro-arrhythmogenic effects of the T634S-hERG mutation: insights from a simulation study.Interface Focus. 2023 Dec 15;13(6):20230035. doi: 10.1098/rsfs.2023.0035. eCollection 2023 Dec 6. Interface Focus. 2023. PMID: 38106919 Free PMC article.
-
Pro-arrhythmic effects of gain-of-function potassium channel mutations in the short QT syndrome.Philos Trans R Soc Lond B Biol Sci. 2023 Jun 19;378(1879):20220165. doi: 10.1098/rstb.2022.0165. Epub 2023 May 1. Philos Trans R Soc Lond B Biol Sci. 2023. PMID: 37122211 Free PMC article. Review.
-
Computational analysis of arrhythmogenesis in KCNH2 T618I mutation-associated short QT syndrome and the pharmacological effects of quinidine and sotalol.NPJ Syst Biol Appl. 2022 Nov 4;8(1):43. doi: 10.1038/s41540-022-00254-5. NPJ Syst Biol Appl. 2022. PMID: 36333337 Free PMC article.
-
The Genetics and Epigenetics of Ventricular Arrhythmias in Patients Without Structural Heart Disease.Front Cardiovasc Med. 2022 Jun 15;9:891399. doi: 10.3389/fcvm.2022.891399. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35783865 Free PMC article. Review.
-
Investigation of the Effects of the Short QT Syndrome D172N Kir2.1 Mutation on Ventricular Action Potential Profile Using Dynamic Clamp.Front Pharmacol. 2022 Jan 18;12:794620. doi: 10.3389/fphar.2021.794620. eCollection 2021. Front Pharmacol. 2022. PMID: 35115940 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
